IACIX | JVMTX | IACIX / JVMTX | |
Total Expense Ratio | 0.85 | 1.00 | 85% |
Annual Report Gross Expense Ratio | 1.13 | 1.11 | 102% |
Fund Existence | 23 years | 12 years | - |
Gain YTD | 0.000 | 3.456 | - |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 282M | 21.8B | 1% |
Annual Yield % from dividends | 1.73 | 0.71 | 244% |
Returns for 1 year | 0.80 | -4.36 | -18% |
Returns for 3 years | -15.33 | 12.71 | -121% |
Returns for 5 years | 35.49 | 61.31 | 58% |
Returns for 10 years | -9.43 | 35.64 | -26% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XTJA | 27.94 | -0.37 | -1.29% |
Innovator US Equity Acclrtd Pls ETF Jan | |||
USSE | 30.82 | -0.60 | -1.91% |
Segall Bryant & Hamill Select Equity ETF | |||
CHI | 10.20 | -0.21 | -2.02% |
Calamos Convertible Opportunities and Income Fund | |||
EPRF | 17.32 | -0.36 | -2.04% |
Innovator S&P Investment Grade Prfrd ETF | |||
IBB | 121.69 | -2.98 | -2.39% |
iShares Biotechnology ETF |